These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34405521)

  • 1. Cardiovascular and renal disease manifestation and healthcare resource utilization in patients on first-line oral therapy for type 2 diabetes: A claims-based observational cohort study.
    Olufade T; Jiang L; Israni R; Huang J; Gosmanov AR
    Diabetes Obes Metab; 2021 Dec; 23(12):2741-2751. PubMed ID: 34405521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
    Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical Outcomes and Healthcare Resource Utilization in a Real-World Population Reflecting the DAPA-CKD Trial Participants.
    Olufade T; Lamerato L; Sánchez JJG; Jiang L; Huang J; Nolan S; Rangaswami J
    Adv Ther; 2021 Feb; 38(2):1352-1363. PubMed ID: 33474707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower heart failure and chronic kidney disease risks associated with sodium-glucose cotransporter-2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.
    Komuro I; Kadowaki T; Bodegård J; Thuresson M; Okami S; Yajima T
    Diabetes Obes Metab; 2021 Apr; 23 Suppl 2():19-27. PubMed ID: 33835641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database.
    Fried L; Schmedt N; Folkerts K; Bowrin K; Raad H; Batech M; Kovesdy C
    Nephrol Dial Transplant; 2023 Feb; 38(3):630-643. PubMed ID: 35389468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.
    Norhammar A; Bodegard J; Eriksson JW; Haller H; Linssen GCM; Banerjee A; Karasik A; Mamouris P; Tangri N; Taveira-Gomes T; Maggioni AP; Botana M; Thuresson M; Okami S; Yajima T; Kadowaki T; Birkeland KI;
    Diabetes Obes Metab; 2022 Jul; 24(7):1277-1287. PubMed ID: 35322567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and Renal Outcomes in Patients with Type-2 Diabetes and Chronic Kidney Disease Identified in a United States Administrative Claims Database: A Population Cohort Study.
    Folkerts K; Kelly AMB; Petruski-Ivleva N; Fried L; Blankenburg M; Gay A; Velentgas P; Kovesdy CP
    Nephron; 2021; 145(4):342-352. PubMed ID: 33789294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower risk of hospitalization for heart failure, kidney disease and death with sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease: A retrospective cohort study in UK primary care.
    Idris I; Zhang R; Mamza JB; Ford M; Morris T; Banerjee A; Khunti K
    Diabetes Obes Metab; 2021 Oct; 23(10):2207-2214. PubMed ID: 33973690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
    King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C
    Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Health Care Resource Utilization and Costs Among Patients With Type 2 Diabetes and Either Cardiovascular Disease or Cardiovascular Risk Factors An Analysis of a US Health Insurance Database.
    Meyers J; Hoog M; Mody R; Yu M; Davis K
    Clin Ther; 2021 Nov; 43(11):1827-1842. PubMed ID: 34625283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.
    Birkeland KI; Bodegard J; Eriksson JW; Norhammar A; Haller H; Linssen GCM; Banerjee A; Thuresson M; Okami S; Garal-Pantaler E; Overbeek J; Mamza JB; Zhang R; Yajima T; Komuro I; Kadowaki T
    Diabetes Obes Metab; 2020 Sep; 22(9):1607-1618. PubMed ID: 32363737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term costs in patients with chronic kidney disease treated with dapagliflozin: a retrospective cohort study.
    Dwyer JP; Agiro A; Desai P; Cremisi H
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(9):1057-1066. PubMed ID: 37540162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient characteristics and initiation of mineralocorticoid receptor antagonists in patients with chronic kidney disease in routine clinical practice in the US: a retrospective cohort study.
    Blankenburg M; Fett AK; Eisenring S; Haas G; Gay A
    BMC Nephrol; 2019 May; 20(1):171. PubMed ID: 31096928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Risk Models to Identify Patients at High-Risk for Severe Clinical Outcomes With Chronic Kidney Disease and Type 2 Diabetes.
    Sheer R; Nair R; Pasquale MK; Evers T; Cockrell M; Gay A; Singh R; Schmedt N
    J Prim Care Community Health; 2022; 13():21501319211063726. PubMed ID: 35068244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and resource use in Spanish type 2 diabetes patients without previous cardiorenal disease: CaReMe Spain study summary.
    Sicras-Mainar A; Sicras-Navarro A; Palacios B; Sequera M; Blanco J; Hormigo A; Manito N; Alcázar-Arroyo R; Botana-Lopez MA
    Endocrinol Diabetes Nutr (Engl Ed); 2022; 69(7):509-519. PubMed ID: 36084988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease begets heart failure and vice versa: temporal associations between heart failure events in relation to incident chronic kidney disease in type 2 diabetes.
    Wu MZ; Teng TK; Tay WT; Ren QW; Tromp J; Ouwerkerk W; Chandramouli C; Huang JY; Chan YH; Teramoto K; Yu SY; Lawson C; Li HL; Tse YK; Li XL; Hung D; Tse HF; Lam CSP; Yiu KH
    Diabetes Obes Metab; 2023 Mar; 25(3):707-715. PubMed ID: 36346045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record study.
    Pasea L; Dashtban A; Mizani M; Bhuva A; Morris T; Mamza JB; Banerjee A
    Open Heart; 2023 Sep; 10(2):. PubMed ID: 37758654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study.
    Chu L; Fuller M; Jervis K; Ciaccia A; Abitbol A
    Clin Ther; 2021 Sep; 43(9):1558-1573. PubMed ID: 34426012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
    Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
    J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database.
    Blin P; Joubert M; Jourdain P; Zaoui P; Guiard E; Sakr D; Dureau-Pournin C; Bernard MA; Lassalle R; Thomas-Delecourt F; Bineau S; Moore N; Droz-Perroteau C
    Cardiovasc Diabetol; 2024 Jan; 23(1):22. PubMed ID: 38195491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.